Advancing excellence in laboratory medicine for better healthcare worldwide

About us (C-EBLM)

Terms of reference

The aims and objectives of the Committee on Evidence-based Laboratory Medicine are to:

1.       Promote the understanding and the methodology of EBLM by educating laboratory professionals about

  • how to find the evidence
  • how to appraise the evidence
  • how to act on evidence

2.       Support rational laboratory use by implementation of results from EBLM into daily practice. This can be achieved by methodological  research, international surveys and by educating laboratory professionals in the following topics:

  • How to perform primary diagnostic studies
  • How to carry out systematic reviews in laboratory medicine
  • How to make evidence-based guideline recommendations in laboratory medicine
  • How to implement evidence-based diagnostic guidelines in clinical practice

3.       Promote the international dissemination of and collaboration in EBLM

Committee membership

Terms of members are indicated in the C-EBLM's page of the IFCC website

Members

  • Chair: Chris Florkowski, Clinical Biochemistry Unit, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand chris.florkowski@cdhb.govt.nz
  • Member: Annalise Zemlin, University of Stellenbosch and Tygerberg Hospital,Cape Town, South Africa  azemlin@sun.ac.za 
  • Member: Hernan Fares Taie, Instituto de Análisis Fares Taie, Mar del Plata, Argentina laboratorio@farestaie.com.ar 
  • Member: Karina Rodríguez-Capote, Clinical Chemist, DynaLIFEDx, #200, 10150-102 Street, Edmonton, Alberta, Canada, T5J 5E2 karina.capote@dynalifedx.com 
  • Member: Julien Wils, Pharmacology Department, University Hospital of Rouen, France wilsjulien@gmail.com 

Consultants

List of Corresponding Members, nominated by National Societies

Name Full Member Society
J. Whitfield  Australasian Association of Clinical Biochemists (AACB)
A. Don-Wauchope Canadian Society for Clinical Chemistry (CSCC)
D. Rogic Croatian Society for Medical Biochemistry (HDMB)
P. Jorgensen Danish Society of Clinical Biochemistry (DSKB)
R. Lange German Society of Clinical Chemistry and Laboratory Medicine
E. Nagy Hungarian Society of Clinical Biochemistry
V. Thakur Association of Clinical Biochemists of India (ACBI)
D.Astrawinata Indonesian Association for Clinical Chemistry (HKKI)
Y. Dickstein Israel Society for Clinical Laboratory Science
P. Pezzati Italian Society of Clinical Chemistry and Clinical Molecular Biology (SIBioC)
V. Banys Lithuanian Society of Laboratory Medicine
H. Isah Association of Clinical Chemists Nigeria (ACCN)
H.K.Ayesha  Pakistan Society of Chemical Patholosgists
G.J. Sousa Portugese Society of Clinical Chemistry (SPQC)
N. Majkic Singh Society of Medical Biochemists of Serbia (SMBS)
J. Vavrik Slovak Society of Clinical Biochemistry (SSKB)
N. Gimenez Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC)
R. Sugathadasa Association for Clinical Biochemistry, Sri Lanka
C. Queijo Association Bioquimica Uruguaya (ABU)
S. Kahn  American Association for Clinical Chemistry (AACC)
S. Demir Turkish Biochemical Society (TBS)
S. Manley The Association for Clinical Biochemistry (ACB)
R.Vinod Mahato  Nepalese Association for Clinical Chemistry (NAAC)

List of Corresponding Members, nominated by Corporate Members

Name Corporate
R. Schneider Abbott Laboratories
R. Thomae Mitsubishi Chemical Europe
K. Olson Siemens Healthcare Diagnostics
O. Hauss Sismex Europe

 How to become a member or corresponding member of the committee?

The organisational framework of IFCC Divisions and Committees can be viewed in the IFCC handbook.

To become a member or corresponding member of the committee, candidates should submit a formal application with a brief plan (max. 250 words) of their contribution to the aims and objectives of the C-EBLM. A short CV (max. 1 page), underlining the qualifications and prior experience or publications in evidence-based (laboratory) medicine, should also be attached. Members and corresponding members should be officially recommended by their National Society and a formal letter of support should accompany the application. Applications will be reviewed and officially endorsed by the Executive Committee of the Education and Management Division (EC-EMD) of IFCC, and the EMD and/or C-EBLM chair will officially inform successful candidates.

Applications, including:

  • the application form
  • a letter of support signed by the president of the candidate's national society, and
  • curriculum vitae of the candidate

should be addressed to the chairperson of the committee

Members should have prior knowledge and experience in EBM or EBLM. Members are expected to participate actively in the activities of the Committee. Membership involves approximately 2-3 days commitment per month. Failure to contribute significantly may result in the loss of membership.

Corresponding members: The committee is open to corresponding membership from member organisations of IFCC. One corresponding member should represent the IFCC member state in the committee. Applications are welcome from countries which are not yet represented in the committee (see membership area). Corresponding members should be interested in evidence based medicine. Prior experience in evidence-based methodology is an advantage. Candidates should be active in EBLM or related fields in their own countries. Corresponding members are expected to form a link and a communication channel between the C-EBLM and the relevant national professional organisation(s).

Corresponding membership involves approximately one day commitment per month.

Consultants are either former members of C-EBLM or external experts who support the activities of the committee and advise on specific matters, at the request of the chairperson of the committee.

Collaborations

 
Website developed by Insoft Digital